| 000 | 01834 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517033425.0 | ||
| 264 | 0 | _c20160308 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1878-5905 | ||
| 024 | 7 |
_a10.1016/j.biomaterials.2015.04.058 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, Chih-Cheng | |
| 245 | 0 | 0 |
_aRegulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR. _h[electronic resource] |
| 260 |
_bBiomaterials _cAug 2015 |
||
| 300 |
_a141-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdiagnosis |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 | _aBiomechanical Phenomena |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCollagen Type I _xanalysis |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xanalysis |
| 650 | 0 | 4 |
_aErlotinib Hydrochloride _xpharmacology |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aIntegrins _xanalysis |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMechanotransduction, Cellular |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xanalysis |
| 650 | 0 | 4 |
_aSulfones _xpharmacology |
| 700 | 1 | _aHsieh, Ting-Lieh | |
| 700 | 1 | _aTiong, Tung-Yu | |
| 700 | 1 | _aHsiao, Chi-Hao | |
| 700 | 1 | _aJi, Andrea Tung-Qian | |
| 700 | 1 | _aHsu, Wei-Tse | |
| 700 | 1 | _aLee, Oscar K | |
| 700 | 1 | _aHo, Jennifer H | |
| 773 | 0 |
_tBiomaterials _gvol. 60 _gp. 141-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biomaterials.2015.04.058 _zAvailable from publisher's website |
| 999 |
_c24926534 _d24926534 |
||